Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Miss Susan Moug
+44 (0)141 314 6965
susanmoug@nhs.net


Study Location:

Find another location


Questions to ask
Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - The feasibility of performing a walking programme in patients with rectal cancer undergoing chemo-radiotherapy (the REx trial)
Back

The feasibility of performing a walking programme in patients with rectal cancer undergoing chemo-radiotherapy (the REx trial)

Not Recruiting

Open to: All Genders

Age: Adult

Paisley

Medical Conditions

Rectal cancer

This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 Jun 2014 01 Jun 2016

Publications

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30657249 feasibility results (added 21/01/2019)2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32564236/ muscle mass results (added 22/06/2020)

Interventional

Intervention Type : Other
Intervention Description : The patients randomized to the walking group will have a consultation with the Project Co-ordinator (PC) where the walking intervention, including the use of the pedometer, will be explained with stepping count targets described. Pedometers have been used successfully by this research team and have been shown to be a motivational tool, which will increase walking in the short term and sustain walking over 12 months. The walking programme will consist of 15-17 weeks of intervention with the first 6 weeks consisting of graduated bi-weekly goals.The aim will be that walking behaviour is either maintained over the remaining weeks or increased according to the individual. The goal is for the participants to increase their average daily step count by 3000 accumulated above their baseline value: based on the assumption that an adult walking at a moderate pace produces 100 steps/minute, an increase of 3000 steps on 5 days of the week would correspond to approximately 150 minutes of moderate physical activity over the course of the week, which is the recommended physical activity level for older adults in Scotland.

Control group: No walking intervention




You can take part if:



You may not be able to take part if:


1. Chemotherapy and radiotherapy not first-line treatment2. Patient has had previous malignancies3. Significant co-morbidity where inclusion into this trial would put the patientÂ’s health at risk4. Patient has any mental, physical or psychological impairment that prevents them from giving signed informed consent5. Patient is already achieving their recommended activity level per week where participation in a walking programme would mean he/she would be exercising at a lower level than normal


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Royal Alexandra Hospital
    Paisley
    PA2 9PN

This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.

Miss Susan Moug
+44 (0)141 314 6965
susanmoug@nhs.net



The study is sponsored by NHS Greater Glasgow and Clyde (UK) and funded by Chief Scientist Office (UK), ref.: CZH/4/984.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN62859294

Or CPMS 16471

Last updated 25 October 2022

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top